22 July 2020: A set of NCL Phlebotomy FAQs: Urgent and Essential Bloods has been published.
17 July 2020: For up to date information on phlebotomy services, please use the phlebotomy updates page on the NCL GP Coronavirus GP intranet.
Please read the latest update on phlebotomy services in North Central London here (17 July 2020, full updates on services provided by North Middlesex University Hospital, Royal Free London, University College London Hospitals, Whittington Health)
1 May 2020: North London Partners has issued further guidance including changes in the pathwway and delivery of GP direct-access phlebotomy. All clinics will be pre-booked and forms will need to be emailed direct to a booking office in order to save patients from having to collect or handle forms. The providers will arrange for requests to be printed onto the correct paper, including the self-adhesive sample labels, for use by the phlebotomist.
The following detailed information/instructions are available:
Please continue to use pathology services sparingly, so that capacity is protected for high risk monitoring and other essential activity.
6 April 2020: Covid-19
- Most North Central London general hospital sites are still providing phlebotomy services during the Covid-19 outbreak, however this has been limited to urgent patients and those requiring drug monitoring at North Middlesex University Hospital and the Royal Free. The Atrium at University College London Hospital has been closed.
- Most community phlebotomy sites are closed.
- Domiciliary services for housebound patients are under pressure but continue to deliver.
- Hospital anticoagulation clinics continue to provide a good service monitoring those patients under their care.
LCS and QoF Target testing: GPs are reminded that testing should be performed if there is a clinical indication and testing purely for QoF or LCS payments can stop. Payments will continue.
Patient transport to essential monitoring appointments: Patients within the shielded group who are required to attend appointments for essential monitoring (e.g. anti-coagulation clinics/phlebotomy services) are eligible for voluntary patient transport.